Alzheimers Association California Article
Alzheimers And An Aging Population
By Brendan Wilde
With an aging global population, it is not surprising the focus of attention has been placed squarely on the shoulders of Alzheimer's disease; being
the most common progressive degenerative disorder makes it especially noteworthy. Alzheimer's disease gradually causes deterioration in the memory and is currently
affecting one in ten of people aged 65 and over; although current diagnosis is not perfect, the accuracy levels are up to 94 percent at best, 87 percent at worst.
Discovered in 1906 by German physician Alois Alzheimer, the world's focus on this disease is only about 30 years old; its effects are not fully understood even today
with all the research that has been carried out. Getting older is the main risk surrounding Alzheimer's according to research. Unfortunately, the person
experiencing the early symptoms of Alzheimer's will know something is wrong but won't admit it to others or even to themselves; until this happens it is hard to start
any form of treatment. General measures for treatment of Alzheimer's disease are the same as for all dementias. Unfortunately, because there is still so much
that is unknown about the disease, there is no definite way to treat it although some symptoms can be improved or slowed down with drugs. The three main
medications currently approved for treatments of Alzheimer's disease are: Donepezil, Tacrine, and Rivastigmine; they can improve the mental faculties of patients with
this condition by up to 26 weeks. Memantine is a new drug that slows deterioration during the later stages and is a derivative of the decades old
anti-influenza drug Amantadine; this new drug is used on patients with moderate to severe Alzheimer's already receiving Donepezil. Memantine side effects are
minimal but it is the first treatment to show a distinct effect on patients with a serious condition; as 80 percent of the drug is passed in urine unchanged there is very
little left to cause any harm. The average age of a person living in the industrialized world is increasing which is making Alzheimer's disease a major health
issue to be looked into; in the United States it is fourth in the list of fatal diseases. Although contracting the disease is a tragedy, the cost of treatment and care for
sufferers is causing economic vibrations everywhere; with an annual cost of 40 billion US dollars for care and treatment, looking after patients is set to be a major
problem. Nearly half the annual budget was spent on research into the condition last year by the National Institute of Aging; currently there are over 300 different
compounds at various stages of development for its treatment. To help you reduce the chance of contracting dementia, it's important to adopt a healthy
lifestyle, choose carefully what you eat and drink and take more exercise. In fact researchers believe the happier and healthier someone is with Alzheimer's, the
slower his or her decline. Luckily, early-onset symptoms of this disease are very rare because it primarily affects the elderly; there have however, been recent
occasions (although rare) where a younger person has developed this condition. Recommended Products
____________________
Alzheimers Association California News
|
16 Aug 2008 at 7:55pm John McCain doesn?t get much press with his stale, re-warmed Bush policies,so he character assassinates Obama. When McCain stands before his pre-screened crowds, and tells them Obama is just a celebrity, elitist, not in touch with the people. It ... Read more...
14 Aug 2008 at 12:34pm With apologies to those of you with Tony Orlando songs still stuck in your head - here's the afternoon wild card... At DFO's request, I'm taking another run at blog-sitting while he's on vacation. And so, I'm making a plea to all of you to help me ... Read more...
13 Aug 2008 at 7:59pm Caller-Times file Randy Moffett, chairman of the Southland Conference, discusses the eventual inclusion of Texas A&M University-Corpus Christi into the conference in mid-2005 with university officials including Sandra Harper (from left), Dan Viola ... Read more...
6 Aug 2008 at 8:03pm The Better Part: Is it Alzheimer's?KMVT
28 min - Aug 7, 2008Have you ever asked yourself about a friend or family member, is it just normal memory loss or is it Alzheimer's? How can we tell? Can anything be done to avoid or delay this cruel disease? Carter Wells was a member of 'The Better Part'. He died in 2003 of Alzheimer's. His wife Marjorie is convinced that identifying the disease early and early interception are the key. Part 1 of a 2-Part Program. Also view: Diagnosis Alzheimer's. Guest: William Fisher, CEO Alzheimer's Association, Northern California Host: Val Jeffery, The Better Part Alzheimer's Association (24/7) Helpline: 800-272-3900 Produced by: Val Jeffery Directed by: Ernie Piini Edited by: Val Jeffery Read more...
5 Aug 2008 at 5:37pm The Better Part: Diagnosis Alzheimer'sKMVT
28 min - Aug 5, 2008You or a loved one is diagnosed with Alzheimer's. What can you expect? How do you cope? In our previous program, "Is it Alzheimer's?", we talked about identifying Alzheimer's at an early stage but what if the diagnosis is Alzheimer's? This program covers what to expect, treatment options, help and support. Carter Wells was a member of "The Better Part". He died in 2003 of Alzheimer's. Both Alzheimer's programs were inspired by his wife Marjorie. Guest: William Fisher, CEO Alzheimer's Association, Northern California. Host: Val Jeffery, 'The Better Part' Alzheimer's Association (24/7) Helpline: 800-272-3900 Produced by: Val Jeffery Directed by: Ernie Piini Edited by: Val Jeffery Read more...
9 Jul 2008 at 4:54pm Early Detection of Alzheimer's Disease - A Virtual Town Hall Meeting
1 hr 45 min - Jul 9, 2008On Wednesday, 9 July 2008, 2:00-3:30 p.m. (U.S. EST), Alzforum held a Virtual Town Hall on a subject of tremendous strategic importance in the fight against Alzheimer disease: early detection. Alzforum was honored to welcome our guest moderator, Harold Varmus, Nobel laureate, former director of the National Institutes of Health, and president and CEO of Memorial Sloan-Kettering Cancer Center. Dr. Varmus is a member of the Alzheimer?s Study Group (ASG), an independent working group mandated by the United States Congress to develop a national strategic plan for Alzheimer disease (see ARF related news story). This Webinar will be transcribed and delivered to the ASG. We thank the Geoffrey Beene Foundation Alzheimer's Initiative for its generous sponsorship of this town hall. Registration is required. There is a consensus among AD researchers that therapies will be most effective if given early. But how can treatments be developed when there are not yet accepted diagnostics or clinical trial designs for such early-stage AD trials? Even if such therapies are developed, how will the public be educated and motivated to ask for early diagnosis? How will physicians respond? The past decade has seen encouraging progress in both the tools for early diagnosis and in candidate drugs. The Alzforum has invited a panel of thought leaders to give brief presentations about the most promising advances and frustrating bottlenecks in their areas of expertise. The panel members and their presentations were as follows: Welcome June Kinoshita, Executive Editor, Alzheimer Research Forum Introductory remarks Harold Varmus, M.D., President and CEO, Memorial Sloan-Kettering Cancer Center About the Alzheimer's Study Group Rob Egge, Center for Health Transformation The strategic importance and challenges of early detection of AD Sid Gilman, M.D., Director, Michigan Alzheimer's Disease Research Center Early-stage and preclinical AD John Morris, M.D., Director, Alzheimer's Disease Research Center, Washington University St. Louis Imaging biomarkers for early detection of AD Michael W. Weiner, M.D., Principal Investigator, Alzheimer's Disease Neuroimaging Initiative Director, Center for Imaging of Neurodegenerative Disease, VA Medical Center, San Francisco Early detection of AD: fluid biomarkers Anne Fagan, Ph.D., Research Associate Professor of Neurology, Washington University, St. Louis Translating early detection to the clinic Doug Galasko, M.D., Interim Director of UCSD Shiley-Marcos Alzheimer?s Disease Research Center The role of clinical and research Centers of Excellence in early diagnosis Rachelle Smith Doody, M.D., Ph.D., Effie Marie Cain Chair in Alzheimer's Disease Research, Baylor College of Medicine What pharma has/what pharma needs Richard Mohs, PhD., Leader, Alzheimer's Disease Team, Eli Lilly and Company Early detection of AD: The patient's and caregiver's perspective Bill Bridgwater, patient advocate, National Board of Alzheimer's Association Early detection and drug development: a brief overview Paul Aisen, M.D., University of California, San Diego (UCSD) School of Medicine?s Department of Neurosciences, Director of the Alzheimer?s Disease Cooperative Study (ADCS) Read more...
9 May 2008 at 9:31pm Alzheimer's Association Memory Walk 2008: Join Me!sonyarose8
1 min - May 10, 2008The Alzheimer's Association Memory Walk® - http://www.alz.org/memorywalk/ is the nation's largest event to raise awareness and funds for Alzheimer's disease. The money we raise will go toward research to treat and prevent Alzheimer's, and programs to improve the lives of millions of Americans already affected. Join my team "Daydream Believers" that I formed in honor of my terrific aunt Lilli -- (if you don't have a team yet) and become a champion in the cause to end Alzheimer's! Just follow this Link to visit my personal web page/team page and help me in my efforts to support Alzheimer's Association California Southland Chapter- MW: http://2008MemoryWalkLA.kintera.org/faf/r.asp?t=4&i=262586&u=262586-211165905&e=1694198195 Thank you for your support! Read more...
|
Alzheimers Association California Links
|
|
